Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients
- 1 May 1990
- journal article
- Published by Springer Nature in Nature
- Vol. 345 (6270), 84-86
- https://doi.org/10.1038/345084a0
Abstract
Kaposi's sarcoma (KS) is frequently associated with human immunodeficiency virus-1 (HIV-1) infection. Supernatants from HIV-1-infected T cells carrying the CD4 antigen promote the growth of cells derived from KS lesions of AIDS patients (AIDS-KS cells), and the HIV-1 tat gene, introduced into the germ line of mice, induces skin lesions closely resembling KS. Here we report that the tat gene product (Tat) is released from both HIV-1-acutely infected H9 cells and tat-transfected COS-1 cells. These Tat-containing supernatants specifically promote growth of AIDS-KS cells which are inhibited by anti-Tat antibodies; recombinant Tat has the same growth-promoting properties. Therefore a viral regulatory gene product can be released as a biologically active protein and directly act as a growth stimulator. These and previous data indicate that extracellular Tat could be involved in the development or progression, or both, of KS in HIV-1-infected individuals.Keywords
This publication has 19 references indexed in Scilit:
- The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNANature, 1989
- AIDS-Kaposi's Sarcoma-Derived Cells Express Cytokines with Autocrine and Paracrine Growth EffectsScience, 1989
- Cultured, aids‐related Kaposi's sarcoma cells express endothelial cell markers and are weakly malignant in vitroInternational Journal of Cancer, 1988
- Kaposi's Sarcoma Cells: Long-Term Culture with Growth Factor from Retrovirus-Infected CD4 + T CellsScience, 1988
- Angiogenic Properties of Kaposi's Sarcoma-Derived Cells After Long-Term Culture in VitroScience, 1988
- The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic miceNature, 1988
- Invasive activity and chemotactic response to growth factors by Kaposi's sarcoma cellsJournal of Cellular Biochemistry, 1988
- Synthesis of the complete trans-activation gene product of human T-lymphotropic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitro.Proceedings of the National Academy of Sciences, 1986
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Disseminated Kaposi's sarcoma syndrome in young homosexual menJournal of the American Academy of Dermatology, 1981